| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5526811 | European Journal of Cancer | 2017 | 4 Pages |
Abstract
Soft tissue and visceral sarcoma gather a large group of rare to very rare cancers and locally aggressive connective tissue tumours. Novel concepts on histological and molecular classification, optimal management of patients, systemic adjuvant and neoadjuvant treatment have been emerging in the last 5 years. In the present publication, we review and summarise significant changes which impact on disease management in this group of rare cancers.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jean-Yves Blay, Mehdi Brahmi, Isabelle Ray-Coquard,